Company Filing History:
Years Active: 2009-2012
Title: Masao Nawano: Innovator in Glucokinase Activating Agents
Introduction
Masao Nawano is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of glucokinase activating agents. With a total of 2 patents, Nawano's work is recognized for its potential impact on metabolic disorders.
Latest Patents
Nawano's latest patents focus on oxime derivatives and their preparations. The primary aim of these inventions is to provide useful compounds that act as glucokinase activating agents. The oxime derivative of the formula [I] is characterized by Ring A, which can be aryl or heteroaryl. This innovative approach addresses critical challenges in the treatment of conditions related to glucose metabolism.
Career Highlights
Masao Nawano is affiliated with Mitsubishi Tanabe Pharma Corporation, where he continues to advance his research and development efforts. His work is instrumental in the pharmaceutical industry, contributing to the creation of new therapeutic options for patients.
Collaborations
Nawano has collaborated with notable colleagues, including Kazutoshi Sugawara and Tetsuji Matsudaira. These partnerships enhance the research environment and foster innovation within the company.
Conclusion
Masao Nawano's contributions to the field of glucokinase activating agents exemplify the importance of innovation in pharmaceuticals. His patents and collaborative efforts position him as a key figure in advancing medical science.